Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT–YB1–MDR1 Signaling Pathway
2016
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
2008
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
2014
HER2+ Breast Cancer Therapy: By CPP-ZFN Mediated Targeting of mTOR?
2012
Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells
2016
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
2009
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
2019 Standout
Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire
2015
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
2008
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
The translational landscape of mTOR signalling steers cancer initiation and metastasis
2012 Nature
Synthesis and evaluation of indole, pyrazole, chromone and pyrimidine based conjugates for tumor growth inhibitory activities – Development of highly efficacious cytotoxic agents
2010
ApoE4 Accelerates Early Seeding of Amyloid Pathology
2017
IDH1andIDH2Mutations in Gliomas
2009 Standout
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
2011
Y-box factor YB1 controls p53 apoptotic function
2005
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Structure and function of the blood–brain barrier
2009 Standout
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs
2008
Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression
2010
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Rapamycin: One Drug, Many Effects
2014 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Tight junctions and the regulation of gene expression
2008
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Identification of synthetic lethality of PLK1 inhibition and microtubule-destabilizing drugs
2015
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
Some p53-binding proteins that can function as arbiters of life and death
2006
Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?
2012
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
2014 Standout
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
p53 in health and disease
2007 Standout
Post-transcriptional Up-regulation of Tsc-22 by Ybx1, a Target of miR-216a, Mediates TGF-β-induced Collagen Expression in Kidney Cells*
2010
Reflecting on 25 years with MYC
2008 Standout
Hallmarks of Cellular Senescence
2018 Standout
Regulation of type I interferon responses
2013 Standout
Filomicelles in nanomedicine – from flexible, fragmentable, and ligand-targetable drug carrier designs to combination therapy for brain tumors
2013
An RNA-centric dissection of host complexes controlling flavivirus infection
2019 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
2016
Y Box-binding Protein-1 Binds to the Dengue Virus 3′-Untranslated Region and Mediates Antiviral Effects
2007
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
2009
Immune System Effects of Echinacea, Ginseng, and Astragalus: A Review
2003
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review
2020 Standout
Natural Health Products in the Prevention and Treatment of Osteoporosis: Systematic Review of Randomized Controlled Trials
2006
Muscle damage induced by black cohosh (Cimicifuga racemosa)
2005
eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation
2016 StandoutNatureNobel
OSU-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species–Related Autophagy in Hepatocellular Carcinoma
2008
Review of the Botanical Characteristics, Phytochemistry, and Pharmacology of Astragalus membranaceus (Huangqi)
2014 Standout
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
2019 Standout
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
Effects of Soy Isoflavones and Conjugated Equine Estrogens on Inflammatory Markers in Atherosclerotic, Ovariectomized Monkeys
2005
Initial testing (stage 1) of the polo‐like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program
2013
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Diabetes and Cancer
2010 Standout
The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
2014
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Identification of Internal Ribosome Entry Segment (IRES)-trans-Acting Factors for the Myc Family of IRESs
2007
Enhancing the Efficacy of Drug-loaded Nanocarriers against Brain Tumors by Targeted Radiation Therapy
2013
ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas
2015
Mechanisms of Diabetic Complications
2013 Standout
2013
Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).
2014
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in Tumors
2007
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Works of Cathy Lee being referenced
YB-1 Bridges Neural Stem Cells and Brain Tumor–Initiating Cells via Its Roles in Differentiation and Cell Growth
2011
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2009
Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O 6-methylguanine-DNA methyltransferase
2009
Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice
2008
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours
2005
Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2006
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells
2005
Botanical dietary supplement use in peri- and postmenopausal women
2003
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative
2012
Plasma Signaling Proteins in Persons at Genetic Risk for Alzheimer Disease
2012
FoxG1 Interacts with Bmi1 to Regulate Self-Renewal and Tumorigenicity of Medulloblastoma Stem Cells
2013
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide
2012